Trastuzumab Emtansine

Records for this ingredient, by country (identity only).

ATC L01FD03 · 12 markets · 30 records

Trastuzumab Emtansine 12 markets · 30 records Forms
Filters
MarketES 6AU 5GB 4US 2CA 2SG 2HK 2JP 2FR 2TW 1EU 1

ES 6 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

  • 160 mg per mL / per unit basis not statedinjectionKADCYLA
  • 100 mg per mL / per unit basis not statedinjectionKADCYLA

AU 5 records · 4 shown of 4 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 160 mg per mL / per unit basis not statedinjectionKADCYLA
  • 100 mg per mL / per unit basis not statedinjectionKADCYLA
  • 171 mg per mL / per unit basis not statedinjectionKADCYLA trastuzumab emtansine (rch) 100 mg powder for injection vial unknown
  • 106 mg per mL / per unit basis not statedinjectionKADCYLA trastuzumab emtansine (rch) 100 mg powder for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KADCYLA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

US 2 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 20 mg per mL / per unit basis not statedinjectionKADCYLA

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KADCYLA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KADCYLA ×2賀癌寧凍晶注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KADCYLA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.